Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Kendra L SchwartzMichael S SimonLauren C BylsmaJulie J RuterbuschJennifer L Beebe-DimmerNeil M SchultzScott C FlandersArie BarlevJon P FryzekRuben G W QuekPublished in: Cancer (2018)
Among older women with advanced TNBC, significant treatment variations and considerable HRU and costs exist. Further research is needed to find effective treatments with which to reduce the clinical and economic burden of this disease. Cancer 2018;124:2104-14. © 2018 American Cancer Society.